ACRF Chemical Biology

ACRF Chemical Biology

Protein structure formed in the process of apoptosis
The ACRF Chemical Biology division investigates key biological processes and pathways critical in disease development to discover potential drug targets important for human disease.
Our researchers use chemical, biochemical, structural and biological approaches to establish how dysregulation of critical cell signalling pathways contributes to disease, and use this to guide novel therapeutic development.

Health impact

Cancers: blood cancers, breast cancers, myeloproliferative disorders, stomach cancers

Immune disorders: Crohn’s disease, inflammatory bowel disease, multiple sclerosis, psoriasis, rheumatic fever and heart disease

Infectious disease: HIV, malaria, toxoplasmosis and vaccines

Other areas: heart disease and stroke, neurodegenerative disease, personalised medicine, thalassemia

Division news

Division publications Division staff numbers

Division head

Associate Professor Guillaume Lessene

Lab heads

Associate Professor Chris Burns, visiting scientist

Dr Ethan Goddard-Borger

Dr Isabelle Lucet

Professor Keith Watson, honorary

Division coordinator

Dr Michelle Lam